{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:53:03Z","timestamp":1769068383335,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12265-022-10271-8","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T16:10:44Z","timestamp":1652371844000},"page":"1352-1365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fasudil Ameliorates Osteoporosis Following Myocardial Infarction by Regulating Cardiac Calcitonin Secretion"],"prefix":"10.1007","volume":"15","author":[{"given":"Chengyu","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeqian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maohua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0041-6180","authenticated-orcid":false,"given":"Dingguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"issue":"3","key":"10271_CR1","doi-asserted-by":"publisher","first-page":"Itc17","DOI":"10.7326\/AITC201708010","volume":"167","author":"KE Ensrud","year":"2017","unstructured":"Ensrud, K. E., & Crandall, C. J. (2017). Osteoporosis. Ann Intern Med, 167(3), Itc17-itc32.","journal-title":"Ann Intern Med"},{"key":"10271_CR2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.mcna.2020.06.004","volume":"104","author":"CB Johnston","year":"2020","unstructured":"Johnston, C. B., & Dagar, M. (2020). Osteoporosis in older adults. Medical Clinics of North America, 104, 873\u2013884.","journal-title":"Medical Clinics of North America"},{"key":"10271_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0140-6736(16)30677-8","volume":"389","author":"GW Reed","year":"2017","unstructured":"Reed, G. W., Rossi, J. E., & Cannon, C. P. (2017). Acute myocardial infarction. Lancet, 389, 197\u2013210.","journal-title":"Lancet"},{"key":"10271_CR4","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/CIRCRESAHA.111.246876","volume":"110","author":"BJ North","year":"2012","unstructured":"North, B. J., & Sinclair, D. A. (2012). The intersection between aging and cardiovascular disease. Circulation Research, 110, 1097\u20131108.","journal-title":"Circulation Research"},{"key":"10271_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jbspin.2016.09.022","volume":"84","author":"M Laroche","year":"2017","unstructured":"Laroche, M., P\u00e9courneau, V., Blain, H., Breuil, V., Chapurlat, R., Cortet, B., Sutter, B., & Degboe, Y. (2017). Osteoporosis and ischemic cardiovascular disease. Joint, Bone, Spine, 84, 427\u2013432.","journal-title":"Joint, Bone, Spine"},{"key":"10271_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MCA.0000000000000306","volume":"27","author":"N Liu","year":"2016","unstructured":"Liu, N., Chen, J., Zhang, K., & Tang, Z. (2016). A community-based study of the relationship between coronary artery disease and osteoporosis in Chinese postmenopausal women. Coronary Artery Disease, 27, 59\u201364.","journal-title":"Coronary Artery Disease"},{"key":"10271_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/0193945916658885","volume":"39","author":"DA Abshire","year":"2017","unstructured":"Abshire, D. A., Moser, D. K., Clasey, J. L., Chung, M. L., Pressler, S. J., Dunbar, S. B., Heo, S., & Lennie, T. A. (2017). Body composition and bone mineral density in patients with heart failure. Western Journal of Nursing Research, 39, 582\u2013599.","journal-title":"Western Journal of Nursing Research"},{"key":"10271_CR8","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jacc.2012.07.042","volume":"60","author":"M G\u00f6ssl","year":"2012","unstructured":"G\u00f6ssl, M., Khosla, S., Zhang, X., Higano, N., Jordan, K. L., Loeffler, D., Enriquez-Sarano, M., Lennon, R. J., McGregor, U., Lerman, L. O., & Lerman, A. (2012). Role of circulating osteogenic progenitor cells in calcific aortic stenosis. Journal of the American College of Cardiology, 60, 1945\u20131953.","journal-title":"Journal of the American College of Cardiology"},{"key":"10271_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00380-009-1221-7","volume":"25","author":"J Oyama","year":"2010","unstructured":"Oyama, J., Satoh, S., Suematsu, N., Kadokami, T., Maeda, T., Sugano, M., & Makino, N. (2010). Scavenging free radicals improves endothelial dysfunction in human coronary arteries in vivo. Heart and Vessels, 25, 379\u2013385.","journal-title":"Heart and Vessels"},{"key":"10271_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.abb.2010.06.008","volume":"503","author":"R Eastell","year":"2010","unstructured":"Eastell, R., Newman, C., & Crossman, D. C. (2010). Cardiovascular disease and bone. Archives of Biochemistry and Biophysics, 503, 78\u201383.","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10271_CR11","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1556\/OH.2012.29503","volume":"153","author":"E Mezosi","year":"2012","unstructured":"Mezosi, E. (2012). Bajnok L and Toth K [The heart as an endocrine organ]. Orvosi Hetilap, 153, 2041\u20132047.","journal-title":"Orvosi Hetilap"},{"key":"10271_CR12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41586-020-2890-8","volume":"587","author":"LM Moreira","year":"2020","unstructured":"Moreira, L. M., Takawale, A., Hulsurkar, M., Menassa, D. A., Antanaviciute, A., Lahiri, S. K., Mehta, N., Evans, N., Psarros, C., Robinson, P., Sparrow, A. J., Gillis, M. A., Ashley, N., Naud, P., Barallobre-Barreiro, J., Theofilatos, K., Lee, A., Norris, M., Clarke, M. V., \u2026 Reilly, S. (2020). Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia. Nature, 587, 460\u2013465.","journal-title":"Nature"},{"key":"10271_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/CIRCULATIONAHA.117.028388","volume":"136","author":"AA Aubdool","year":"2017","unstructured":"Aubdool, A. A., Thakore, P., Argunhan, F., Smillie, S. J., Schnelle, M., Srivastava, S., Alawi, K. M., Wilde, E., Mitchell, J., Farrell-Dillon, K., Richards, D. A., Maltese, G., Siow, R. C., Nandi, M., Clark, J. E., Shah, A. M., Sams, A., & Brain, S. D. (2017). A novel \u03b1-calcitonin gene-related peptide analogue protects against end-organ damage in experimental hypertension, cardiac hypertrophy, and heart failure. Circulation, 136, 367\u2013383.","journal-title":"Circulation"},{"key":"10271_CR14","doi-asserted-by":"publisher","first-page":"e019169","DOI":"10.1161\/JAHA.120.019169","volume":"10","author":"VFM Segers","year":"2021","unstructured":"Segers, V. F. M., & De Keulenaer, G. W. (2021). Autocrine signaling in cardiac remodeling: A rich source of therapeutic targets. Journal of the American Heart Association., 10, e019169.","journal-title":"Journal of the American Heart Association."},{"key":"10271_CR15","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.bmcl.2016.03.113","volume":"26","author":"S Shah","year":"2016","unstructured":"Shah, S., & Savjani, J. (2016). A review on ROCK-II inhibitors: From molecular modelling to synthesis. Bioorganic & Medicinal Chemistry Letters, 26, 2383\u20132391.","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10271_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s12012-019-09561-6","volume":"20","author":"Y Yan","year":"2020","unstructured":"Yan, Y., Xiang, C., Yang, Z., Miao, D., & Zhang, D. (2020). Rho kinase inhibition by fasudil attenuates adriamycin-induced chronic heart injury. Cardiovascular Toxicology, 20, 351\u2013360.","journal-title":"Cardiovascular Toxicology"},{"key":"10271_CR17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/bcpt.12895","volume":"122","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Zhang, H., Yang, Z., Miao, D., & Zhang, D. (2018). Rho kinase inhibitor, fasudil, attenuates contrast-induced acute kidney injury. Basic & Clinical Pharmacology & Toxicology, 122, 278\u2013287.","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10271_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jphs.2020.10.002","volume":"145","author":"C Xiang","year":"2021","unstructured":"Xiang, C., Yan, Y., & Zhang, D. (2021). Alleviation of the doxorubicin-induced nephrotoxicity by fasudil in vivo and in vitro. Journal of Pharmacological Sciences, 145, 6\u201315.","journal-title":"Journal of Pharmacological Sciences"},{"key":"10271_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/jgm.1473","volume":"12","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., Altman, D. G., Group NCRRGW. (2010). Animal research: reporting in vivo experiments: The ARRIVE guidelines. J Gene Med., 12, 561\u20133.","journal-title":"J Gene Med."},{"key":"10271_CR20","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","volume":"160","author":"JC McGrath","year":"2010","unstructured":"McGrath, J. C., Drummond, G. B., McLachlan, E. M., Kilkenny, C., & Wainwright, C. L. (2010). Guidelines for reporting experiments involving animals: The ARRIVE guidelines. British Journal of Pharmacology, 160, 1573\u20131576.","journal-title":"British Journal of Pharmacology"},{"key":"10271_CR21","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1111\/bph.12955","volume":"172","author":"JC McGrath","year":"2015","unstructured":"McGrath, J. C., & Lilley, E. (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): New requirements for publication in BJP. Br J Pharmacol, 172, 3189\u201393.","journal-title":"Br J Pharmacol"},{"key":"10271_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.120.050446","volume":"144","author":"R Gao","year":"2021","unstructured":"Gao, R., Wang, L., Bei, Y., Wu, X., Wang, J., Zhou, Q., Tao, L., Das, S., Li, X., & Xiao, J. (2021). Long Noncoding RNA cardiac physiological hypertrophy-associated regulator induces cardiac physiological hypertrophy and promotes functional recovery after myocardial ischemia-reperfusion injury. Circulation, 144, 303\u2013317.","journal-title":"Circulation"},{"key":"10271_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2018.01.007","volume":"822","author":"YS Zhang","year":"2018","unstructured":"Zhang, Y. S., Tang, L. J., Tu, H., Wang, S. J., Liu, B., Zhang, X. J., Li, N. S., Luo, X. J., & Peng, J. (2018). Fasudil ameliorates the ischemia\/reperfusion oxidative injury in rat hearts through suppression of myosin regulatory light chain\/NADPH oxidase 2 pathway. European Journal of Pharmacology, 822, 1\u201312.","journal-title":"European Journal of Pharmacology"},{"key":"10271_CR24","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1039\/C5BM00140D","volume":"3","author":"J Sapudom","year":"2015","unstructured":"Sapudom, J., Rubner, S., Martin, S., Thoenes, S., Anderegg, U., & Pompe, T. (2015). The interplay of fibronectin functionalization and TGF-\u03b21 presence on fibroblast proliferation, differentiation and migration in 3D matrices. Biomaterials science., 3, 1291\u20131301.","journal-title":"Biomaterials science."},{"key":"10271_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13046-018-0995-9","volume":"38","author":"R Wang","year":"2019","unstructured":"Wang, R., Sun, Y., Yu, W., Yan, Y., Qiao, M., Jiang, R., Guan, W., & Wang, L. (2019). Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT. Journal of Experimental & Clinical Cancer Research, 38, 20.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10271_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1440-1681.2011.05523.x","volume":"38","author":"H Zhou","year":"2011","unstructured":"Zhou, H., Zhang, K. X., Li, Y. J., Guo, B. Y., Wang, M., & Wang, M. (2011). Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts. Clinical and Experimental Pharmacology and Physiology, 38, 387\u2013394.","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10271_CR27","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1359\/JBMR.050711","volume":"20","author":"LB Tank\u00f3","year":"2005","unstructured":"Tank\u00f3, L. B., Christiansen, C., Cox, D. A., Geiger, M. J., McNabb, M. A., & Cummings, S. R. (2005). Relationship between osteoporosis and cardiovascular disease in postmenopausal women. Journal of Bone and Mineral Research, 20, 1912\u20131920.","journal-title":"Journal of Bone and Mineral Research"},{"key":"10271_CR28","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00198-019-05031-5","volume":"30","author":"D Liu","year":"2019","unstructured":"Liu, D., Chen, L., Dong, S., Peng, Z., Yang, H., Chen, Y., Li, L., Zhou, H., & Zhou, R. (2019). Bone mass density and bone metabolism marker are associated with progression of carotid and cardiac calcified plaque in Chinese elderly population. Osteoporosis International, 30, 1807\u20131815.","journal-title":"Osteoporosis International"},{"key":"10271_CR29","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s00198-019-05042-2","volume":"30","author":"G Ge","year":"2019","unstructured":"Ge, G., Li, J., & Wang, Q. (2019). Heart failure and fracture risk: A meta-analysis. Osteoporosis International, 30, 1903\u20131909.","journal-title":"Osteoporosis International"},{"key":"10271_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nature11260","volume":"487","author":"P Dutta","year":"2012","unstructured":"Dutta, P., Courties, G., Wei, Y., Leuschner, F., Gorbatov, R., Robbins, C. S., Iwamoto, Y., Thompson, B., Carlson, A. L., Heidt, T., Majmudar, M. D., Lasitschka, F., Etzrodt, M., Waterman, P., Waring, M. T., Chicoine, A. T., van der Laan, A. M., Niessen, H. W., Piek, J. J., \u2026 Nahrendorf, M. (2012). Myocardial infarction accelerates atherosclerosis. Nature, 487, 325\u2013329.","journal-title":"Nature"},{"key":"10271_CR31","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby, P. (2002). Inflammation in atherosclerosis. Nature, 420, 868\u2013874.","journal-title":"Nature"},{"key":"10271_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13075-018-1523-1","volume":"20","author":"M Ohtsuji","year":"2018","unstructured":"Ohtsuji, M., Lin, Q., Okazaki, H., Takahashi, K., Amano, H., Yagita, H., Nishimura, H., & Hirose, S. (2018). Anti-CD11b antibody treatment suppresses the osteoclast generation, inflammatory cell infiltration, and autoantibody production in arthritis-prone Fc\u03b3RIIB-deficient mice. Arthritis Research & Therapy, 20, 25.","journal-title":"Arthritis Research & Therapy"},{"key":"10271_CR33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/17425255.2016.1175436","volume":"12","author":"L Bandeira","year":"2016","unstructured":"Bandeira, L., Lewiecki, E. M., & Bilezikian, J. P. (2016). Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis. Expert Opinion on Drug Metabolism & Toxicology, 12, 681\u2013689.","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10271_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev.med.46.1.249","volume":"46","author":"KM Prestwood","year":"1995","unstructured":"Prestwood, K. M., Pilbeam, C. C., & Raisz, L. G. (1995). Treatment of osteoporosis. Annual Review of Medicine, 46, 249\u2013256.","journal-title":"Annual Review of Medicine"},{"key":"10271_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/2021303a0","volume":"202","author":"GV Foster","year":"1964","unstructured":"Foster, G. V., Baghdiantz, A., Kumar, M. A., Slack, E., Soliman, H. A., & Macintyre, I. (1964). THYROID ORIGIN OF CALCITONIN. Nature, 202, 1303\u20131305.","journal-title":"Nature"},{"key":"10271_CR36","doi-asserted-by":"publisher","first-page":"108944","DOI":"10.1016\/j.cbi.2020.108944","volume":"317","author":"M Chen","year":"2020","unstructured":"Chen, M., Luo, D., Zhan, J., Hou, Y., Chen, S., Li, X., & Lin, D. (2020). Fasudil enhanced differentiation of BMSCs in vivo and vitro, involvement of P38 signaling pathway. Chemico-Biological Interactions, 317, 108944.","journal-title":"Chemico-Biological Interactions"},{"key":"10271_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1507\/endocrj.K09E-328","volume":"57","author":"I Kanazawa","year":"2010","unstructured":"Kanazawa, I., Yamaguchi, T., Yano, S., Yamauchi, M., & Sugimoto, T. (2010). Fasudil hydrochloride induces osteoblastic differentiation of stromal cell lines, C3H10T1\/2 and ST2, via bone morphogenetic protein-2 expression. Endocrine Journal, 57, 415\u2013421.","journal-title":"Endocrine Journal"},{"key":"10271_CR38","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000181162","volume":"95","author":"K Momma","year":"2009","unstructured":"Momma, K., Toyoshima, K., Sun, F., & Nakanishi, T. (2009). In vivo dilatation of the ductus arteriosus by Rho kinase inhibition in the rat. Neonatology, 95, 324\u2013331.","journal-title":"Neonatology"},{"key":"10271_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jconrel.2021.04.030","volume":"334","author":"TA Al-Hilal","year":"2021","unstructured":"Al-Hilal, T. A., Hossain, M. A., Alobaida, A., Alam, F., Keshavarz, A., Nozik-Grayck, E., Stenmark, K. R., German, N. A., & Ahsan, F. (2021). Design, synthesis and biological evaluations of a long-acting, hypoxia-activated prodrug of fasudil, a ROCK inhibitor, to reduce its systemic side-effects. Journal of Controlled Release, 334, 237\u2013247.","journal-title":"Journal of Controlled Release"},{"key":"10271_CR40","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jacc.2006.06.082","volume":"49","author":"K Noma","year":"2007","unstructured":"Noma, K., Goto, C., Nishioka, K., Jitsuiki, D., Umemura, T., Ueda, K., Kimura, M., Nakagawa, K., Oshima, T., Chayama, K., Yoshizumi, M., Liao, J. K., & Higashi, Y. (2007). Roles of Rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness. Journal of the American College of Cardiology, 49, 698\u2013705.","journal-title":"Journal of the American College of Cardiology"},{"key":"10271_CR41","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2009.04.025","volume":"207","author":"DJ Wu","year":"2009","unstructured":"Wu, D. J., Xu, J. Z., Wu, Y. J., Jean-Charles, L., Xiao, B., Gao, P. J., & Zhu, D. L. (2009). Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice. Atherosclerosis, 207, 68\u201373.","journal-title":"Atherosclerosis"},{"key":"10271_CR42","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1093\/cvr\/cvz234","volume":"116","author":"W Li","year":"2020","unstructured":"Li, W., Zhang, Z., Li, X., Cai, J., Li, D., Du, J., Zhang, B., Xiang, D., Li, N., & Li, Y. (2020). CGRP derived from cardiac fibroblasts is an endogenous suppressor of cardiac fibrosis. Cardiovascular Research, 116, 1335\u20131348.","journal-title":"Cardiovascular Research"},{"key":"10271_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13167-016-0055-5","volume":"7","author":"T Kezeli","year":"2016","unstructured":"Kezeli, T., Rukhadze, T., Gongadze, N., Sukoyan, G., Dolidze, N., Chipashvili, M., & Mirziashvili, M. (2016). Effect of calcitonin gene-related peptide antagonist on the cardiovascular events, mortality, and prostaglandin E2 production by nitrate-induced tolerant rats with acute myocardial infarction. The EPMA journal., 7, 6.","journal-title":"The EPMA journal."},{"key":"10271_CR44","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3389\/fphys.2019.00821","volume":"10","author":"A Kumar","year":"2019","unstructured":"Kumar, A., Potts, J. D., & DiPette, D. J. (2019). Protective role of \u03b1-calcitonin gene-related peptide in cardiovascular diseases. Frontiers in Physiology, 10, 821.","journal-title":"Frontiers in Physiology"},{"key":"10271_CR45","doi-asserted-by":"publisher","first-page":"16702","DOI":"10.1073\/pnas.0705974104","volume":"104","author":"K Tsujikawa","year":"2007","unstructured":"Tsujikawa, K., Yayama, K., Hayashi, T., Matsushita, H., Yamaguchi, T., Shigeno, T., Ogitani, Y., Hirayama, M., Kato, T., Fukada, S., Takatori, S., Kawasaki, H., Okamoto, H., Ikawa, M., Okabe, M., & Yamamoto, H. (2007). Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc Natl Acad Sci U S A., 104, 16702\u201316707.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10271_CR46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.bor.0000127824.42507.68","volume":"16","author":"NC Walsh","year":"2004","unstructured":"Walsh, N. C., & Gravallese, E. M. (2004). Bone loss in inflammatory arthritis: Mechanisms and treatment strategies. Current Opinion in Rheumatology, 16, 419\u2013427.","journal-title":"Current Opinion in Rheumatology"},{"key":"10271_CR47","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","volume":"12","author":"N Bucay","year":"1998","unstructured":"Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., Boyle, W. J., & Simonet, W. S. (1998). osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes & Development, 12, 1260\u20131268.","journal-title":"Genes & Development"},{"key":"10271_CR48","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1161\/CIRCULATIONAHA.112.104828","volume":"125","author":"SM Moe","year":"2012","unstructured":"Moe, S. M. (2012). Klotho: A master regulator of cardiovascular disease? Circulation, 125, 2181\u20132183.","journal-title":"Circulation"},{"key":"10271_CR49","doi-asserted-by":"publisher","first-page":"E575","DOI":"10.1210\/jc.2011-2836","volume":"97","author":"M Schoppet","year":"2012","unstructured":"Schoppet, M., Hofbauer, L. C., Brinskelle-Schmal, N., Varennes, A., Goudable, J., Richard, M., Hawa, G., Chapurlat, R., & Szulc, P. (2012). Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: The STRAMBO study. Journal of Clinical Endocrinology and Metabolism, 97, E575\u2013E583.","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10271_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2165\/00024677-200403020-00006","volume":"3","author":"M Munoz-Torres","year":"2004","unstructured":"Munoz-Torres, M., Alonso, G., & Raya, M. P. (2004). Calcitonin therapy in osteoporosis. Treat Endocrinol., 3, 117\u2013132.","journal-title":"Calcitonin therapy in osteoporosis. Treat Endocrinol."},{"key":"10271_CR51","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1161\/CIRCULATIONAHA.111.044164","volume":"125","author":"U Hofmann","year":"2012","unstructured":"Hofmann, U., Beyersdorf, N., Weirather, J., Podolskaya, A., Bauersachs, J., Ertl, G., Kerkau, T., & Frantz, S. (2012). Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation, 125, 1652\u20131663.","journal-title":"Circulation"},{"key":"10271_CR52","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/CIRCRESAHA.115.306532","volume":"118","author":"H Shimokawa","year":"2016","unstructured":"Shimokawa, H., Sunamura, S., & Satoh, K. (2016). RhoA\/Rho-kinase in the cardiovascular system. Circulation Research, 118, 352\u2013366.","journal-title":"Circulation Research"},{"key":"10271_CR53","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1152\/physrev.00021.2012","volume":"93","author":"G Loirand","year":"2013","unstructured":"Loirand, G., Sauzeau, V., & Pacaud, P. (2013). Small G proteins in the cardiovascular system: Physiological and pathological aspects. Physiological Reviews, 93, 1659\u20131720.","journal-title":"Physiological Reviews"},{"key":"10271_CR54","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1253\/circj.CJ-16-0433","volume":"80","author":"T Shimizu","year":"2016","unstructured":"Shimizu, T., & Liao, J. K. (2016). Rho Kinases and Cardiac Remodeling. Circulation Journal, 80, 1491\u20131498.","journal-title":"Circulation Journal"},{"key":"10271_CR55","doi-asserted-by":"publisher","first-page":"H1804","DOI":"10.1152\/ajpheart.01078.2007","volume":"294","author":"A Phrommintikul","year":"2008","unstructured":"Phrommintikul, A., Tran, L., Kompa, A., Wang, B., Adrahtas, A., Cantwell, D., Kelly, D. J., & Krum, H. (2008). Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction. American Journal of Physiology. Heart and Circulatory Physiology, 294, H1804\u2013H1814.","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-022-10271-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-022-10271-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-022-10271-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T18:15:51Z","timestamp":1670264151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-022-10271-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10271"],"URL":"https:\/\/doi.org\/10.1007\/s12265-022-10271-8","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"27 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in strict accordance with the Guidelines for the Care and Use of Laboratory Animals (NIH Publication, revised 2011), which were also approved by the Animal Care and Use Committee of Nanjing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}